Dynamic range of focus recovery in presbyopes after laser scleral microporation
While considered by many to be a “normal process of aging,” the loss of the dynamic focusing function of the eye, presbyopia, is a progressive disease of ocular aging. Presbyopia affects approximately 1.8 billion people globally.1 Estimated global annual productivity losses are approximately 0.037% of the global gross domestic
product in presbyopic adults less than 65 years of age.2
This socioeconomic issue is particularly problematic in developing countries where people are less likely to find visual correction.As people depend upon glasses or bifocals to perform near tasks, there is a decrease in health-related quality of life (HRQOL) and an increase in the risk of ocular diseases. Presbyopia is correlated with ocular rigidity, glaucoma, ocular hypertension, dysfunctional lens syndrome, age-related macular degeneration and cataracts, which can contribute to the effects of aging on ocular tissues.3
Explore More Articles
Laser scleral microporation treatment may be ‘game changer’ for presbyopia
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia. Hipsley said it is important to understand that presbyopia is an aging disease rather than a refractive disorder. Catching it early and treating it can be beneficial for patients. Zhu said laser …
read moreAce Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websites
Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for eye health, specifically Laser Scleral Microporation (LSM), a laser therapeutic designed to rejuvenate the …
read moreAce Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group announced that it has named Val Kolesnitchenko, MD, as Chief Scientific Officer. Dr. Kolesnitchenko has served in leadership roles for three decades in clinical ophthalmology practice and industry. Most recently, he held the position of Executive Director of Global Scientific Affairs at Bausch + Lomb, overseeing the medical and clinical development of the …
read more